COMP <GO>
NWL vs TMO // RETURN ON INVESTED CAPITAL (ROIC)
Newell Brands Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: NWL 2
— TMO 8
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: TMO
LAST: $5.08 (-2.49%) • MKT CAP: $2.16B
roic
0.50%
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
roic
9.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NWL VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NWL | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 33.80% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 0.50% | 9.30% | -8.80 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 30.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 12.20% | 2.40% | +9.80 | NWL | /fcf-yield <GO> |
| Operating Margin | 0.50% | 17.40% | -16.90 | TMO | /operating-margins <GO> |
| Net Profit Margin | -4.00% | 15.10% | -19.10 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | -5.00% | 3.90% | -8.90 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 5.55% | 0.24% | +5.31 | NWL | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.44 | 4.50 | -4.06 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 8/9 | -3.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 40.1 | 62.9 | -22.78 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 36.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.16B | $262.22B | -$260.05B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NWL REV | TMO REV | NWL GROSS % | TMO GROSS % | NWL FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $7.20B | $44.56B | 33.8% | — | $264.0M | $6.29B |
| FY 2024 | $7.58B | $42.88B | 33.6% | — | $496.0M | $7.27B |
| FY 2023 | $8.13B | $42.86B | — | — | $930.0M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NWL // BETA —
TMO // BETA 0.94